Patents by Inventor Charles V. Magatti

Charles V. Magatti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
    Patent number: 4971972
    Abstract: Antihypertensive phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan derivative portion are disclosed.
    Type: Grant
    Filed: March 23, 1989
    Date of Patent: November 20, 1990
    Assignee: Schering Corporation
    Inventors: Ronald J. Doll, Deen Tulshian, Charles V. Magatti
  • Antiglaucoma compositions and methods
    Patent number: 4840772
    Abstract: The present invention relates to ophthalmological pharmaceutical compositions comprising (benzothiadiazine, benzamide and benzenesulfonyl)phenyl-substituted carboxyalkyl dipeptide compounds and to methods for using said composition in reducing intraocular pressure, e.g., in the treatment of glaucoma.
    Type: Grant
    Filed: August 3, 1988
    Date of Patent: June 20, 1989
    Assignee: Schering Corporation
    Inventors: Robert Watkins, Ronald J. Doll, Bernard R. Neustadt, Elizabeth M. Smith, Charles V. Magatti, Elijah H. Gold
  • Antihypertensive acylpyrazines
    Patent number: 4803206
    Abstract: Acylpyrazines useful in the treatment of hypertension are disclosed.
    Type: Grant
    Filed: March 7, 1988
    Date of Patent: February 7, 1989
    Assignee: Schering Corporation
    Inventors: Charles V. Magatti, Ronald J. Doll
  • Antiglaucoma compositions and methods
    Patent number: 4783444
    Abstract: The present invention relates to ophthalmological pharmaceutical compositions comprising (benzothiadiazine, benzamide and benzenesulfonyl)phenyl-substituted carboxyalkyl dipeptide compounds and to methods for using said composition in reducing intraocular pressure, e.g., in the treatment of glaucoma.
    Type: Grant
    Filed: April 4, 1986
    Date of Patent: November 8, 1988
    Assignee: Schering Corporation
    Inventors: Robert Watkins, Ronald J. Doll, Bernard R. Neustadt, Elizabeth M. Smith, Charles V. Magatti, Elijah H. Gold
  • Process for preparing a specific diastereomer of a monoamino dicarboxylic acid ester
    Patent number: 4691049
    Abstract: (Benzothiadiazine, benzamido and benzenesulfonyl)phenyl-substituted carboxyalkyl dipeptide compounds are disclosed. Compounds of this invention are useful as antihypertensive agents.
    Type: Grant
    Filed: February 20, 1986
    Date of Patent: September 1, 1987
    Assignee: Schering Corporation
    Inventors: Ronald J. Doll, Bernard R. Neustadt, Elizabeth M. Smith, Charles V. Magatti, Elijah H. Gold
  • Antihypertensive agents
    Patent number: 4584285
    Abstract: (Benzothiadiazine, benzamido and benzenesulfonyl)phenyl-substituted carboxyalkyl dipeptide compounds are disclosed. Compounds of this invention are useful as antihypertensive agents.
    Type: Grant
    Filed: September 17, 1984
    Date of Patent: April 22, 1986
    Assignee: Schering Corporation
    Inventors: Ronald J. Doll, Bernard R. Neustadt, Elizabeth M. Smith, Charles V. Magatti, Elijah H. Gold
  • Antihypertensive benzothiadiazines
    Patent number: 4468396
    Abstract: This invention relates to benzothiadiazinyl-substituted carboxyalkyl dipeptides useful as combined antihypertensive and diuretic agents.
    Type: Grant
    Filed: December 20, 1982
    Date of Patent: August 28, 1984
    Assignee: Schering Corporation
    Inventor: Charles V. Magatti